156 related articles for article (PubMed ID: 19995586)
1. Controlled in situ preparation of A beta(1-42) oligomers from the isopeptide "iso-A beta(1-42)", physicochemical and biological characterization.
Bozso Z; Penke B; Simon D; Laczkó I; Juhász G; Szegedi V; Kasza A; Soós K; Hetényi A; Wéber E; Tóháti H; Csete M; Zarándi M; Fülöp L
Peptides; 2010 Feb; 31(2):248-56. PubMed ID: 19995586
[TBL] [Abstract][Full Text] [Related]
2. Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats.
Wang XH; Li L; Hölscher C; Pan YF; Chen XR; Qi JS
Neuroscience; 2010 Nov; 170(4):1239-48. PubMed ID: 20727946
[TBL] [Abstract][Full Text] [Related]
3. O-acyl isopeptide method: development of an O-acyl isodipeptide unit for Boc SPPS and its application to the synthesis of Aβ1-42 isopeptide.
Yoshiya T; Uemura T; Maruno T; Kubo S; Kiso Y; Sohma Y; Kobayashi Y; Yoshizawa-Kumagaye K; Nishiuchi Y
J Pept Sci; 2014 Sep; 20(9):669-74. PubMed ID: 24889810
[TBL] [Abstract][Full Text] [Related]
4. The 'O-acyl isopeptide method' for the synthesis of difficult sequence-containing peptides: application to the synthesis of Alzheimer's disease-related amyloid beta peptide (Abeta) 1-42.
Sohma Y; Hayashi Y; Kimura M; Chiyomori Y; Taniguchi A; Sasaki M; Kimura T; Kiso Y
J Pept Sci; 2005 Jul; 11(8):441-51. PubMed ID: 15761877
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin-1 prevents amyloid β-induced impairment of long-term potentiation in hippocampal slices via ErbB4.
Min SS; An J; Lee JH; Seol GH; Im JH; Kim HS; Baik TK; Woo RS
Neurosci Lett; 2011 Nov; 505(1):6-9. PubMed ID: 21787838
[TBL] [Abstract][Full Text] [Related]
8. DCP-LA neutralizes mutant amyloid beta peptide-induced impairment of long-term potentiation and spatial learning.
Nagata T; Tomiyama T; Mori H; Yaguchi T; Nishizaki T
Behav Brain Res; 2010 Jan; 206(1):151-4. PubMed ID: 19716848
[TBL] [Abstract][Full Text] [Related]
9. An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments.
Fezoui Y; Hartley DM; Harper JD; Khurana R; Walsh DM; Condron MM; Selkoe DJ; Lansbury PT; Fink AL; Teplow DB
Amyloid; 2000 Sep; 7(3):166-78. PubMed ID: 11019857
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of Nucleated Conformational Conversion of Aβ42.
Fu Z; Aucoin D; Davis J; Van Nostrand WE; Smith SO
Biochemistry; 2015 Jul; 54(27):4197-207. PubMed ID: 26069943
[TBL] [Abstract][Full Text] [Related]
11. Alpha4beta2 nicotinic acetylcholine receptors are required for the amyloid beta protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo.
Wu MN; He YX; Guo F; Qi JS
Brain Res Bull; 2008 Sep; 77(2-3):84-90. PubMed ID: 18602971
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of chemically-tethered amyloid-β segment trimer possessing amyloidogenic properties.
Shinoda K; Sohma Y; Kanai M
Bioorg Med Chem Lett; 2015 Aug; 25(15):2976-9. PubMed ID: 26048787
[TBL] [Abstract][Full Text] [Related]
13. A2T and A2V Aβ peptides exhibit different aggregation kinetics, primary nucleation, morphology, structure, and LTP inhibition.
Murray B; Sorci M; Rosenthal J; Lippens J; Isaacson D; Das P; Fabris D; Li S; Belfort G
Proteins; 2016 Apr; 84(4):488-500. PubMed ID: 26799157
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of the amyloid β40 dimer model with a linker at position 30 adjacent to the intermolecular β-sheet region.
Murakami K; Suzuki T; Hanaki M; Monobe Y; Akagi K; Irie K
Biochem Biophys Res Commun; 2015 Oct; 466(3):463-7. PubMed ID: 26367176
[TBL] [Abstract][Full Text] [Related]
15. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
[TBL] [Abstract][Full Text] [Related]
16. Beta-amyloid protein aggregation.
Etienne MA; Edwin NJ; Aucoin JP; Russo PS; McCarley RL; Hammer RP
Methods Mol Biol; 2007; 386():203-25. PubMed ID: 18604947
[TBL] [Abstract][Full Text] [Related]
17. Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide.
Huang TH; Yang DS; Plaskos NP; Go S; Yip CM; Fraser PE; Chakrabartty A
J Mol Biol; 2000 Mar; 297(1):73-87. PubMed ID: 10704308
[TBL] [Abstract][Full Text] [Related]
18. Secondary structure and interfacial aggregation of amyloid-beta(1-40) on sodium dodecyl sulfate micelles.
Rangachari V; Reed DK; Moore BD; Rosenberry TL
Biochemistry; 2006 Jul; 45(28):8639-48. PubMed ID: 16834338
[TBL] [Abstract][Full Text] [Related]
19. Hexafluoroisopropanol induces self-assembly of β-amyloid peptides into highly ordered nanostructures.
Pachahara SK; Chaudhary N; Subbalakshmi C; Nagaraj R
J Pept Sci; 2012 Apr; 18(4):233-41. PubMed ID: 22252985
[TBL] [Abstract][Full Text] [Related]
20. Morphology and secondary structure of stable beta-oligomers formed by amyloid peptide PrP(106-126).
Walsh P; Yau J; Simonetti K; Sharpe S
Biochemistry; 2009 Jun; 48(25):5779-81. PubMed ID: 19476383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
